USFDA nod for Natco Pharma’s anti-cancer generic drug

While the 10mg and 60mg strengths, of the product, have received final approval from the regulator, the 30mg strength has got a tentative approval.

from The Hindu - Business https://ift.tt/3glJf0J
via IFTTT